16 Jun 2023 Confo Therapeutics enters into research collaboration for GPCR-targeting antibody discovery with AbCellera Member news
13 Jun 2023 Galapagos appoints Dr. Susanne Schaffert as non-executive independent Director to its Board Member news
12 Jun 2023 Oxurion finalizes enrollment in KALAHARI Phase 2, Part B trial of novel PKal inhibitor THR-149 in diabetic macular edema Member news
07 Jun 2023 SANTERO announces a €8 million Series A funding round led by Newton Biocapital to develop novel antibiotics in the fight against antimicrobial resistance Member news
05 Jun 2023 HERAN Partners co-leads the GBP 6,5m financing round of Hypervision Surgical to support the further development and commercial roll-out of their Hyperspectral Imaging platform Member news
05 Jun 2023 ANeuroTech receives IND approval from the FDA for pivotal Phase IIIB trial of adjunctive anti-depression drug, ANT-01 Member news
02 Jun 2023 Biotalys continues to demonstrate strength of first biocontrol in latest global field trials Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
